Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ANESC provides comprehensive diagnostics and patient care for epilepsy, sleep disorders, movement disorders, dementia, and related neurological conditions. It also serves as a clinical trial site for ongoing studies in epilepsy, including trials such as X-TOLE2/X-TOLE3 and X-ACKT, focused on patients with refractory focal onset and generalized seizures. There are no in-house molecules or therapies but active engagement in multi-center clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Neurology, Epilepsy and Sleep Centers.